- Home
- AGNC vs HALO Comparison
AGNC vs HALO Comparison
Compare AGNC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- HALO
- Stock Information
- Founded
- AGNC 2008
- HALO 1998
- Country
- AGNC United States
- HALO United States
- Employees
- AGNC N/A
- HALO N/A
- Industry
- AGNC Real Estate Investment Trusts
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGNC Real Estate
- HALO Health Care
- Exchange
- AGNC Nasdaq
- HALO Nasdaq
- Market Cap
- AGNC 9.0B
- HALO 7.4B
- IPO Year
- AGNC 2008
- HALO N/A
- Fundamental
- Price
- AGNC $8.96
- HALO $47.91
- Analyst Decision
- AGNC Buy
- HALO Buy
- Analyst Count
- AGNC 11
- HALO 9
- Target Price
- AGNC $9.88
- HALO $63.56
- AVG Volume (30 Days)
- AGNC 31.0M
- HALO 3.0M
- Earning Date
- AGNC 04-21-2025
- HALO 05-06-2025
- Dividend Yield
- AGNC 16.07%
- HALO N/A
- EPS Growth
- AGNC N/A
- HALO 55.40
- EPS
- AGNC 0.40
- HALO 3.76
- Revenue
- AGNC $584,000,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- AGNC $39.36
- HALO $24.79
- Revenue Next Year
- AGNC $22.20
- HALO $22.65
- P/E Ratio
- AGNC $22.55
- HALO $13.36
- Revenue Growth
- AGNC N/A
- HALO 25.64
- 52 Week Low
- AGNC $7.85
- HALO $41.28
- 52 Week High
- AGNC $10.85
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- AGNC 51.20
- HALO 32.31
- Support Level
- AGNC $8.61
- HALO $58.38
- Resistance Level
- AGNC $8.92
- HALO $69.94
- Average True Range (ATR)
- AGNC 0.16
- HALO 3.37
- MACD
- AGNC 0.07
- HALO -1.11
- Stochastic Oscillator
- AGNC 71.43
- HALO 1.78
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.